Literature DB >> 8594522

Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment.

H R McDonald1, H Schatz, R N Johnson, G W Abrams, G C Brown, A J Brucker, D P Han, H Lewis, W F Mieler, S Meyers.   

Abstract

PURPOSE: Peripheral angiomas have been associated with epiretinal membranes and traction retinal detachment. The authors investigated the timing, results, and complications of vitreous surgery to remove the retinal traction and treat the peripheral vascular tumor.
METHODS: The authors reviewed the results of ten eyes that had undergone vitrectomy for macular pucker and/or traction retinal detachment. These eyes had either preoperative or intraoperative treatment of the peripheral tumor.
RESULTS: Patients were followed 4 to 95 months. Six eyes had nonfamilial peripheral acquired retinal hemangioma, three had von Hippel angiomas, and one had multiple large peripheral retinal angiomas associated with extensive retinal telangiectasis. Four eyes received cryotherapy and/or laser photocoagulation 2 to 3 months before surgery. In the remaining six eyes, initial treatment to the peripheral angioma was performed at the time of vitreous surgery. At final follow-up, all eyes were attached without retinal traction. Vision improved in all eyes; six (60%) achieved 20/50 or better visual acuity. Complications included recurrent epiretinal membrane (n=3); nonregressed angiomas (n=3); increased nuclear sclerosis (n=2); and retinal detachment (n=1).
CONCLUSION: Vitreous surgery, when applied to epiretinal membranes or traction retinal detachments associated with peripheral vascular tumors, has a good chance of improving vision. Treatment of the hemangioma, before or during vitrectomy, usually results in tumor regression.

Entities:  

Mesh:

Year:  1996        PMID: 8594522     DOI: 10.1016/s0161-6420(96)30696-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

Review 1.  [Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].

Authors:  N Bornfeld; K-M Kreusel
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

2.  Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.

Authors:  Emily Ying Chew
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 3.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Vasoproliferative tumours of the retina.

Authors:  H Heimann; N Bornfeld; O Vij; S E Coupland; N E Bechrakis; U Kellner; M H Foerster
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

5.  [Juxtapapillary capillary retinal angioma with epiretinal membrane of the macula in familial Von-Hippel-Lindau-Syndrome].

Authors:  K-M Kreusel; N E Bechrakis; H P H Neumann; M H Foerster
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

6.  Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.

Authors:  Xiaoling Liang; Defen Shen; Yongsheng Huang; Chunyue Yin; Christine M Bojanowski; Zhengping Zhuang; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079

7.  A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of wormlike, wavy tangles of filaments.

Authors:  Makoto Inoue; Kazuto Yamazaki; Kei Shinoda; Susumu Ishida; Hajime Shinoda; Kousuke Noda; Yoshihisa Oguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-30       Impact factor: 3.117

8.  Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

Authors:  G Anastassiou; N Bornfeld; A O Schueler; H Schilling; S Weber; D Fluehs; B Jurklies; O Vij; W Sauerwein
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

9.  25-gauge vitrectomy combined with half-fluence photodynamic therapy for the treatment of juxtapapillary retinal capillary hemangioma: a case report.

Authors:  Cesare Mariotti; Alfonso Giovannini; Michele Reibaldi; Michele Nicolai; Andrea Saitta
Journal:  Case Rep Ophthalmol       Date:  2014-05-29

10.  Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide.

Authors:  Shin Cho Suh; Sun Young Jin; Seon Hee Bae; Chul Gu Kim; Jong Woo Kim
Journal:  Korean J Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.